Evaluating SleepWhale Drops for Rest & Resilience

Part of paid clinical trials in New York, New York.

Sponsor
Efforia, Inc
Study ID
NCT07298161
Status
Recruiting
Apply to this trial

Conditions

  • Sleep

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Accepted

Interventions

  • SleepWhale Natural Sleep Drops — DIETARY_SUPPLEMENT
    Broad spectrum hemp extract: 25 mg Broad spectrum hemp extract (CBN): 1.5 mg Proprietary blend of Suntheanine (L-Theanine), GadoMag (Magnesium( Sibelius (Camomile) and M2 (Lion's Mane)

Study Details

30-day study evaluating SleepWhale Natural Sleep Drops (Extra Strength)-formulated to support deeper sleep and better days.

Key Dates

Start date
Aug 25, 2025
Status verified
Dec 2025
Primary completion
Aug 25, 2026
Completion
Aug 25, 2026

Study Design

Enrollment
100 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Single arm where participants act as their own control
    Single arm where participants act as their own control

Primary Outcome Measure

PROMIS Sleep Disturbance Scale [ Time Frame: Change from baseline (Day 1-3) in PROMIS Sleep Disturbance Scale at 4 weeks (Day 28-32) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
EfforiaNew YorkNew York10003
Matthew Amsden
[email protected]
(646) 679-2479

Find similar trials in New York, NY

By research site
Efforia· New York, NY

Related Studies